Supramolecular assembly of multifunctional maspin-mimetic nanostructures as a potent peptide-based angiogenesis inhibitor

Acta Biomaterialia

Volumn 12, Issue C, 2015, Pages 1-10

  Zha, R Helen ^a,b,d   Sur, Shantanu ^b   Boekhoven, Job ^b   Shi, Heidi Y ^b   Zhang, Ming ^b   Stupp, Samuel I ^a,b,c  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Anti angiogenic; g Helix; Maspin; Peptide amphiphile; Self assembly

Indexed keywords

AMPHIPHILES; BIOSYNTHESIS; BLOOD VESSELS; DISEASES; ENDOTHELIAL CELLS; PEPTIDES; RECOMBINANT PROTEINS; SELF ASSEMBLY; SUPRAMOLECULAR CHEMISTRY; TUMORS;

ANGIOGENESIS; ANGIOGENESIS INHIBITORS; ANTI-ANGIOGENIC; ANTI-ANGIOGENIC ACTIVITY; G-HELIX; MASPIN; MIMETICS; PEPTIDE AMPHIPHILES; SUPRAMOLECULAR ASSEMBLIES; TUMOR GROWTH;

NANOSTRUCTURES;

AMPHOPHILE; FIBRONECTIN; MASPIN; MASPIN MIMETIC PEPTIDE AMPHIPHILE; NANOMATERIAL; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ANGIOGENESIS INHIBITOR; PEPTIDE; SERINE PROTEINASE INHIBITOR; SERPIN-B5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL MOTILITY; CELL MOTION; CELL SURFACE; CHORIOALLANTOIS; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG BINDING; DRUG DETERMINATION; DRUG POTENCY; DRUG STABILITY; DRUG SYNTHESIS; EMBRYO; FETUS MEMBRANE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SPECTROFLUOROMETRY; SUPRAMOLECULAR CHEMISTRY; TRANSMISSION ELECTRON MICROSCOPY; UMBILICAL VEIN ENDOTHELIAL CELL; X RAY CRYSTALLOGRAPHY; CHEMISTRY; MOLECULAR MIMICRY;

ANGIOGENESIS INHIBITORS; CIRCULAR DICHROISM; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MOLECULAR MIMICRY; NANOSTRUCTURES; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; SERPINS;

EID: 84927709679     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.11.001     Document Type: Article

References (39)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
3. Noonan DM, Benelli R, Albini A. Angiogenesis and cancer prevention: a vision. Recent Results Cancer Res 2007;174:219-24.
4. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002;2:727-39.
5. Zou Z, Anisowicz A, Hendrix MJC, Thor A, Neveu M, Sheng S, et al. A serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263:526-9.
6. Shi HY, Zhang W, Liang R, Abraham S, Kittrell FS, Medina D, et al. Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res 2001;61:6945-51.
7. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJC. Biological functions of maspin. J Cell Physiol 2006;209:617-24.
8. Zhang M, Volpert O, Shi YH, Bouck N. Maspin is an angiogenesis inhibitor. Nat Med 2000;6:196-9.
9. Qin L, Zhang M. Maspin regulates endothelial cell adhesion and migration through an integrin signaling pathway. J Biol Chem 2010;285:32360-9.
10. Endsley MP, Hu Y, Deng Y, He X, Warejcka DJ, Twining SS, et al. Maspin, the molecular bridge between the plasminogen activator system and 1 integrin that facilitates cell adhesion. J Biol Chem 2011;286:24599-607.
11. Ravenhill L, Wagstaff L, Edwards DR, Ellis V, Bass R. G-helix of maspin mediates effects on cell migration and adhesion. J Biol Chem 2010;285:36285-92.
12. Law RHP, Irving JA, Buckle AM, Ruzyla K, Buzza M, Bashtannyk-Puhalovich TA, et al. The high resolution crystal structure of the human tumor suppressor maspin reveals a novel conformational switch in the G-helix. J Biol Chem 2005;280:22356-64.
13. Hartgerink JD, Beniash E, Stupp SI. Self-assembly and mineralization of self-assembling nanofibers. Science 2001;294:1684-8.
14. Hartgerink JD, Beniash E, Stupp SI. Peptide-amphiphile nanofibers: a versatile scaffold for the preparation of self-assembling materials. Proc Natl Acad Sci USA 2002;99:5133-8.
15. Cui H, Webber MJ, Stupp SI. Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials. Biopolymers 2010;94:1-18.
16. Webber MJ, Kessler JA, Stupp SI. Emerging peptide nanomedicine to regenerate tissues and organs. J Intern Med 2010;267:71-88.
17. Matson JB, Zha RH, Stupp SI. Peptide self-assembly for crafting functional biological materials. Curr Opin Solid State Mater Sci 2011;15:225-35.
18. Webber MJ, Berns EJ, Stupp SI. Supramolecular nanofibers of peptide amphiphiles for medicine. Isr J Chem 2013;53:530-54.
19. Jiang H, Guler MO, Stupp SI. The internal structure of self-assembled peptide amphiphiles nanofibers. Soft Matter 2007;3:454-62.
20. Velichko YS, Stupp SI, Olvera de la Cruz M. Molecular simulation study of peptide amphiphile self-assembly. J Phys Chem B 2008;112:2326-34.
21. Storrie H, Guler MO, Abu-Amara SN, Volberg T, Rao M, Geiger B, et al. Supramolecular crafting of cell adhesion. Biomaterials 2007;28:4608-18.
22. Webber MJ, Tongers J, Newcomb CJ, Marquardt KT, Bauersachs J, Losordo DW, et al. Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc Natl Acad Sci USA 2011;108:13438-43.
23. Ghanaati S, Webber MJ, Unger RE, Orth C, Hulvat JF, Kiehna SE, et al. Dynamic in vivo biocompatibility of angiogenic peptide amphiphile nanofibers. Biomaterials 2009;30:6202-12.
24. Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol 2007;2:249-55.
25. Khan S, Sur S, Newcomb CJ, Appelt EA, Stupp SI. Self-assembling glucagon-like peptide 1-mimetic peptide amphiphiles for enhanced activity and proliferation of insulin-secreting cells. Acta Biomater 2012;8:1685-92.
26. Whitmore L, Wallace BA. Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers 2008;89:392-400.
27. Koehl P, Levitt M. Structure-based conformational preferences of amino acids. Proc Natl Acad Sci USA 1999;96:12524-9.
28. Paramonov SE, Jun HW, Hartgerink JD. Self-assembly of peptide-amphiphile nanofibers: the roles of hydrogen bonding and amphiphilic packing. J Am Chem Soc 2006;128:7291-8.
29. Fuguet E, Ràfols C, Rosés M, Bosch E. Critical micelle concentration of surfactants in aqueous buffered and unbuffered systems. Anal Chim Acta 2005;548:95-100.
30. MacPhee CE, Woolfson DN. Engineered and designed peptide-based fibrous biomaterials. Curr Opin Solid State Mater Sci 2004;8:141-9.
31. Forns P, Lauer-Fields JL, Gao S, Fields GB. Induction of protein-like molecular architecture by monoalkyl hydrocarbon chains. Biopolymers 2000;54:531-46.
32. Eisenberg D, Wilcox W, Eshita SM, Pryciak PM, Ho SP, DeGrado WF. The design, synthesis, and crystallization of an alpha-helical peptide. Proteins Struct Funct Genet 1986;1:16-22.
33. Ho SP, Degrado WF. Design of a 4-helix bundle protein: synthesis of peptides which self-associate into a helical protein. J Am Chem Soc 1987;109:6751-8.
34. Cella N, Contreras A, Latha K, Rosen JM, Zhang M. Maspin is physically associated with 1 integrin regulating cell adhesion in mammary epithelial cells. FASEB J 2006;20:1510-2.
35. Bass R, Wagstaff L, Ravenhill L, Ellis V. Binding of extracellular maspin to 1 integrins inhibits vascular smooth muscle cell migration. J Biol Chem 2009;284:27712-20.
36. Arnaoutova I, Kleinman HK. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc 2010;5:628-35.
37. West DC, Thompson WD, Sells PG, Burbridge MF. Angiogenesis assays using chick chorioallantoic membrane. Methods Mol Med 2001;46:107-29.
38. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Cao Y, et al. Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harb Symp Quant Biol 1994;59:471-82.
39. Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996;98:671-9.